Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-25-023759
Filing Date
2025-03-13
Accepted
2025-03-13 17:15:36
Documents
77
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0232553-10k_cadrenal.htm   iXBRL 10-K 1492714
2 AMENDED AND RESTATED INSIDER TRADING POLICY ea023255301ex19-1_cadrenal.htm EX-19.1 50452
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea023255301ex23-1_cadrenal.htm EX-23.1 1791
4 CERTIFICATION ea023255301ex31-1_cadrenal.htm EX-31.1 12519
5 CERTIFICATION ea023255301ex31-2_cadrenal.htm EX-31.2 12661
6 CERTIFICATION ea023255301ex32-1_cadrenal.htm EX-32.1 5326
7 CERTIFICATION ea023255301ex32-2_cadrenal.htm EX-32.2 4953
8 GRAPHIC image_001.jpg GRAPHIC 8432
9 GRAPHIC image_002.jpg GRAPHIC 22568
10 GRAPHIC image_003.jpg GRAPHIC 10755
11 GRAPHIC image_004.jpg GRAPHIC 5336
12 GRAPHIC image_005.jpg GRAPHIC 56848
13 GRAPHIC image_006.jpg GRAPHIC 11852
  Complete submission text file 0001213900-25-023759.txt   6296067

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE cvkd-20241231.xsd EX-101.SCH 45318
15 XBRL CALCULATION FILE cvkd-20241231_cal.xml EX-101.CAL 45294
16 XBRL DEFINITION FILE cvkd-20241231_def.xml EX-101.DEF 222512
17 XBRL LABEL FILE cvkd-20241231_lab.xml EX-101.LAB 468877
18 XBRL PRESENTATION FILE cvkd-20241231_pre.xml EX-101.PRE 252848
79 EXTRACTED XBRL INSTANCE DOCUMENT ea0232553-10k_cadrenal_htm.xml XML 509832
Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41596 | Film No.: 25736838
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)